High-density lipoprotein functionality in patients with hyperbaric oxygen therapy

High-density lipoprotein (HDL) cholesterol levels are associated with decreased risk of atherosclerotic disease, but also not all HDL are  functionally equivalent. The functional status of HDL is closely linked to its primary protein component, apolipoprotein A-1 (ApoA-I) levels and paraoxonase 1 (PON1) enzyme. Functional changes of HDL may arise from hyperbaric oxygen therapy (HBO) induced posttranslational modification of ApoA-1 and PON1 levels. A total of 41 patients who met the research criteria were included in the study. On average, 30 sessions of HBO therapy were performed (range: 20-39). Laboratory measurements were performed at the beginning and at the end of HBO treatment in two groups of the same patients. We measured serum levels of Apo A-1, PON1, oxidized LDL (OxLDL) and routine lipid laboratory parameters to determine possible changes in HDL function with HBO therapy. As unexpected, long term HBO treatment have no effect on OxLDL and also on PON1 enzyme. However, the mean ApoA-1 values in the second group were statistically significantly increased than their pre-treatment values (P < 0.003). This preliminary study showed that HBO therapy increased the amount of serum ApoA-1. Actually, it can be assumed that the treatment of HBO does not have a negative effect on HDL functionality. The increase in ApoA-1 with HBO therapy is probably aimed at protecting against oxidative stress in patients. As a result, there is a need for larger clinical trials to determine the possible effects of HBO therapy on HDL functionality.

[1]  F. McGillicuddy,et al.  Unravelling HDL—Looking beyond the Cholesterol Surface to the Quality Within , 2018, International journal of molecular sciences.

[2]  Yoshitaka J. Sei,et al.  Detecting the functional complexities between high-density lipoprotein mimetics. , 2018, Biomaterials.

[3]  G. Aksan,et al.  Serum oxidized low-density lipoprotein level as a marker of oxidative stress in patients undergoing hyperbaric oxygen therapy , 2017 .

[4]  C. White,et al.  High-Density Lipoprotein Regulation of Mitochondrial Function. , 2017, Advances in experimental medicine and biology.

[5]  A. A. Nikitin,et al.  FOXO1 and LXRα downregulate the apolipoprotein A-I gene expression during hydrogen peroxide-induced oxidative stress in HepG2 cells , 2016, Cell Stress and Chaperones.

[6]  G. Chiesa,et al.  High-Density Lipoprotein-Targeted Therapy and Apolipoprotein A-I Mimetic Peptides. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[7]  D. Baláž,et al.  Effect of hyperbaric oxygen on lipoprotein subfractions in diabetic patients. , 2015, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc.

[8]  E. Eren,et al.  HDL functionality and crystal-based sterile inflammation in atherosclerosis. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[9]  E. Eren,et al.  Anticipatory Role of High Density Lipoprotein and Endothelial Dysfunction: An Overview , 2014, The open biochemistry journal.

[10]  E. Eren,et al.  Homocysteine, Paraoxonase-1 and Vascular Endothelial Dysfunction: Omnibus viis Romam Pervenitur. , 2014, Journal of clinical and diagnostic research : JCDR.

[11]  S. Thom,et al.  Hyperbaric Oxygen: Its Mechanisms and Efficacy , 2011, Plastic and reconstructive surgery.

[12]  S. Thom,et al.  The Physiology and Pathophysiology of the Hyperbaric and Diving Environments Oxidative stress is fundamental to hyperbaric oxygen therapy , 2009 .

[13]  Dan S. Tawfik,et al.  High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I. , 2005, Biochemistry.

[14]  A. Gill,et al.  Hyperbaric oxygen: its uses, mechanisms of action and outcomes. , 2004, QJM : monthly journal of the Association of Physicians.

[15]  J. Hink,et al.  Are superoxide and/or hydrogen peroxide responsible for some of the beneficial effects of hyperbaric oxygen therapy? , 2001, Medical hypotheses.